EBOS Group Limited (AU:EBO) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EBOS Group Limited has announced the appointment of Matthew Muscio as a director effective January 1, 2025. Muscio, who previously served as CEO of EBOS Medical Technology, holds 33,687 performance rights in the company. This strategic move may influence EBOS’s presence in the medical technology sector.
For further insights into AU:EBO stock, check out TipRanks’ Stock Analysis page.